36 results
424B3
GRI
GRI Bio Inc
28 Mar 24
Prospectus supplement
4:45pm
and biometric data where the latter is used to uniquely identify an individual are all classified as “special category” data under the GDPR and afforded … assets, accounts payable, accrued expenses and certain liability classified warrants. The carrying amounts reported in the balance sheets for cash
424B3
GRI
GRI Bio Inc
28 Mar 24
Prospectus supplement
4:42pm
and biometric data where the latter is used to uniquely identify an individual are all classified as “special category” data under the GDPR and afforded … assets, accounts payable, accrued expenses and certain liability classified warrants. The carrying amounts reported in the balance sheets for cash
424B4
GRI
GRI Bio Inc
2 Feb 24
Prospectus supplement with pricing info
4:21pm
, no exercise of the Common Warrants being offered in this offering, that no value is attributed to such Common Warrants and that such warrants are classified … Warrants and that such Common Warrants are classified as and accounted for as equity, our as adjusted net tangible book value as of September 30, 2023 would
424B3
ro86rnmj5s ahjovbldt
15 Dec 23
Prospectus supplement
5:02pm
8-K/A
EX-99.1
q0e0g
6 Jul 23
Financial Statements and Exhibits
4:28pm
8-K/A
EX-99.4
nvnk5pqipg5vm ar9
6 Jul 23
Financial Statements and Exhibits
4:28pm
8-K/A
EX-99.2
cdrp040wz6z
6 Jul 23
Financial Statements and Exhibits
4:28pm
S-4
633meto3s8rbz0sern6
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
S-4
EX-4.6
vg87b76tj5p
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
8-K
EX-2.1
jvi230psel0r2l8o03k2
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.5
k0o467zkpjl dy
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm